Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,890 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127,285 | 138,587 |
| Total Cites | 3,540 | 3,968 |
| H-index | 33 | 35 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 125 | 125 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1,668 | 1,761 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1,966 | 2,059 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,032 | 3,244 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
10.79%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,713 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122,297 | 135,045 |
| Total Cites | 3,133 | 3,509 |
| H-index | 32 | 34 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 116 | 116 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1,606 | 1,703 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1,813 | 1,910 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,694 | 2,879 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.22 |
| Self-Citation Percentage |
10.72%
|
|
Chang, F.
Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium,
United Kingdom
2021 Rank: 121,415
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,697 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121,415 | 134,178 |
| Total Cites | 2,928 | 3,248 |
| H-index | 32 | 33 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 109 | 109 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1,566 | 1,661 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1,738 | 1,833 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,512 | 2,672 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
9.85%
|
|
Chang, F.
King's College London,
2020 Rank: 117,212
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 369 out of 19,713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117,212 | 127,520 |
| Total Cites | 2,635 | 2,920 |
| H-index | 31 | 33 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 106 | 106 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 1,538 | 1,633 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1,632 | 1,727 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,253 | 2,394 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.22 |
| Self-Citation Percentage |
9.76%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.